Corti’s new Symphony AI beats OpenAI and Anthropic on medical coding



The Copenhagen-based health AI company built Symphony on peer-reviewed research from the largest medical coding study of its kind, treating coding as a reasoning task rather than a labelling problem. It’s available via API now.


Medical coding, the process of converting clinical notes, diagnoses, and procedures into standardised alphanumeric codes used for billing, reporting, and public health data, is one of healthcare’s most error-prone and consequential administrative tasks.

The American coding system alone, ICD-10-CM, contains 70,000 diagnosis codes. Errors are routine, expensive, and often invisible.

Corti, the Copenhagen-based clinical AI company, has built a product specifically designed to fix this: Symphony for Medical Coding, an agentic system it claims outperforms models from OpenAI, Anthropic, Amazon, Oracle, and Microsoft by up to 25% on clinical accuracy benchmarks.

It is available via API from today.

The performance gap Corti claims is grounded in a methodological distinction. Most AI systems approach medical coding as a classification problem: given a clinical note, predict the most likely code from the training distribution. 

The problem is that coding guidelines change constantly, making historically trained models structurally inadequate. Corti’s approach, developed through a peer-reviewed framework called Code Like Humans, accepted at EMNLP 2025, one of machine learning’s top conferences, treats coding instead as a reasoning task.

“Most AI systems fall short in medical coding because they treat it as labeling, not reasoning. Correct coding depends on evidence, context, hierarchy, and guideline interpretation. We built Symphony for Medical Coding to follow the same decision process expert coders use, and that is why the performance gap is so meaningful,” said Lars Maaløe, PhD, CTO and co-founder of Corti.

The system uses four agents in sequence: an evidence extractor that isolates conditions in a clinical note, an index navigator that searches the ICD alphabetical index for candidate codes, a tabular validator that checks candidates against guidelines, and a code reconciler that sequences and validates the final output. Each step mirrors what a trained human coder does.

The research was based on 1.8 million patient encounters, making it the largest peer-reviewed study of its kind.

The consequences of conventional under-coding are not merely financial. Corti cites a peer-reviewed study of Danish patient data in which its system identified three times as many suicide attempts as had been officially coded, cases that were present in clinical notes and medication records but were missed by coders working under time pressure.

“Medical coding has been treated as a back-office cost center for decades. It isn’t – it’s the data layer that healthcare runs on. Getting it right changes what health systems can see, decide, and do,” said Andreas Cleve, CEO and co-founder of Corti. 

When those cases go uncounted, health systems cannot monitor trends, allocate resources, or design effective interventions. The coding layer is not administrative overhead; it is how health systems see themselves.

Symphony for Medical Coding is the first system Corti has built to operate across both US coding environments, ICD-10-CM for diagnoses, ICD-10-PCS and CPT for procedures, and European coding environments without local retraining.

ICD-10 coverage for Europe, maintained by the WHO, is currently in beta as the company expands into the UK, Germany, France, and Denmark. The system produces auditable outputs: each assigned code is linked to the clinical evidence that supports it, with ambiguities flagged for human review.

It is available through the Corti Console, integrates with the Corti Agentic Framework, and supports both A2A and MCP standards. Enterprise and sovereign cloud deployments are also available.

Corti was founded in Copenhagen and also has offices in New York and London. It has raised $100 million in total and serves more than 100 million patients annually across health systems, including the NHS.

The Symphony launch is the commercial product built on the Code Like Humans research, following Corti’s stated approach of validating ideas in peer-reviewed forums before translating them into production-grade infrastructure.



Source link

Leave a Reply

Subscribe to Our Newsletter

Get our latest articles delivered straight to your inbox. No spam, we promise.

Recent Reviews


As I’m writing this, NVIDIA is the largest company in the world, with a market cap exceeding $4 trillion. Team Green is now the leader among the Magnificent Seven of the tech world, having surpassed them all in just a few short years.

The company has managed to reach these incredible heights with smart planning and by making the right moves for decades, the latest being the decision to sell shovels during the AI gold rush. Considering the current hardware landscape, there’s simply no reason for NVIDIA to rush a new gaming GPU generation for at least a few years. Here’s why.

Scarcity has become the new normal

Not even Nvidia is powerful enough to overcome market constraints

Global memory shortages have been a reality since late 2025, and they aren’t just affecting RAM and storage manufacturers. Rather, this impacts every company making any product that contains memory or storage—including graphics cards.

Since NVIDIA sells GPU and memory bundles to its partners, which they then solder onto PCBs and add cooling to create full-blown graphics cards, this means that NVIDIA doesn’t just have to battle other tech giants to secure a chunk of TSMC’s limited production capacity to produce its GPU chips. It also has to procure massive amounts of GPU memory, which has never been harder or more expensive to obtain.

While a company as large as NVIDIA certainly has long-term contracts that guarantee stable memory prices, those contracts aren’t going to last forever. The company has likely had to sign new ones, considering the GPU price surge that began at the beginning of 2026, with gaming graphics cards still being overpriced.

With GPU memory costing more than ever, NVIDIA has little reason to rush a new gaming GPU generation, because its gaming earnings are just a drop in the bucket compared to its total earnings.

NVIDIA is an AI company now

Gaming GPUs are taking a back seat

A graph showing NVIDIA revenue breakdown in the last few years. Credit: appeconomyinsights.com

NVIDIA’s gaming division had been its golden goose for decades, but come 2022, the company’s data center and AI division’s revenue started to balloon dramatically. By the beginning of fiscal year 2023, data center and AI revenue had surpassed that of the gaming division.

In fiscal year 2026 (which began on July 1, 2025, and ends on June 30, 2026), NVIDIA’s gaming revenue has contributed less than 8% of the company’s total earnings so far. On the other hand, the data center division has made almost 90% of NVIDIA’s total revenue in fiscal year 2026. What I’m trying to say is that NVIDIA is no longer a gaming company—it’s all about AI now.

Considering that we’re in the middle of the biggest memory shortage in history, and that its AI GPUs rake in almost ten times the revenue of gaming GPUs, there’s little reason for NVIDIA to funnel exorbitantly priced memory toward gaming GPUs. It’s much more profitable to put every memory chip they can get their hands on into AI GPU racks and continue receiving mountains of cash by selling them to AI behemoths.

The RTX 50 Super GPUs might never get released

A sign of times to come

NVIDIA’s RTX 50 Super series was supposed to increase memory capacity of its most popular gaming GPUs. The 16GB RTX 5080 was to be superseded by a 24GB RTX 5080 Super; the same fate would await the 16GB RTX 5070 Ti, while the 18GB RTX 5070 Super was to replace its 12GB non-Super sibling. But according to recent reports, NVIDIA has put it on ice.

The RTX 50 Super launch had been slated for this year’s CES in January, but after missing the show, it now looks like NVIDIA has delayed the lineup indefinitely. According to a recent report, NVIDIA doesn’t plan to launch a single new gaming GPU in 2026. Worse still, the RTX 60 series, which had been expected to debut sometime in 2027, has also been delayed.

A report by The Information (via Tom’s Hardware) states that NVIDIA had finalized the design and specs of its RTX 50 Super refresh, but the RAM-pocalypse threw a wrench into the works, forcing the company to “deprioritize RTX 50 Super production.” In other words, it’s exactly what I said a few paragraphs ago: selling enterprise GPU racks to AI companies is far more lucrative than selling comparatively cheaper GPUs to gamers, especially now that memory prices have been skyrocketing.

Before putting the RTX 50 series on ice, NVIDIA had already slashed its gaming GPU supply by about a fifth and started prioritizing models with less VRAM, like the 8GB versions of the RTX 5060 and RTX 5060 Ti, so this news isn’t that surprising.

So when can we expect RTX 60 GPUs?

Late 2028-ish?

A GPU with a pile of money around it. Credit: Lucas Gouveia / How-To Geek

The good news is that the RTX 60 series is definitely in the pipeline, and we will see it sooner or later. The bad news is that its release date is up in the air, and it’s best not to even think about pricing. The word on the street around CES 2026 was that NVIDIA would release the RTX 60 series in mid-2027, give or take a few months. But as of this writing, it’s increasingly likely we won’t see RTX 60 GPUs until 2028.

If you’ve been following the discussion around memory shortages, this won’t be surprising. In late 2025, the prognosis was that we wouldn’t see the end of the RAM-pocalypse until 2027, maybe 2028. But a recent statement by SK Hynix chairman (the company is one of the world’s three largest memory manufacturers) warns that the global memory shortage may last well into 2030.

If that turns out to be true, and if the global AI data center boom doesn’t slow down in the next few years, I wouldn’t be surprised if NVIDIA delays the RTX 60 GPUs as long as possible. There’s a good chance we won’t see them until the second half of 2028, and I wouldn’t be surprised if they miss that window as well if memory supply doesn’t recover by then. Data center GPUs are simply too profitable for NVIDIA to reserve a meaningful portion of memory for gaming graphics cards as long as shortages persist.


At least current-gen gaming GPUs are still a great option for any PC gamer

If there is a silver lining here, it is that current-gen gaming GPUs (NVIDIA RTX 50 and AMD Radeon RX 90) are still more than powerful enough for any current AAA title. Considering that Sony is reportedly delaying the PlayStation 6 and that global PC shipments are projected to see a sharp, double-digit decline in 2026, game developers have little incentive to push requirements beyond what current hardware can handle.

DLSS 5, on the other hand, may be the future of gaming, but no one likes it, and it will take a few years (and likely the arrival of the RTX 60 lineup) for it to mature and become usable on anything that’s not a heckin’ RTX 5090.

If you’re open to buying used GPUs, even last-gen gaming graphics cards offer tons of performance and are able to rein in any AAA game you throw at them. While we likely won’t get a new gaming GPU from NVIDIA for at least a few years, at least the ones we’ve got are great today and will continue to chew through any game for the foreseeable future.



Source link